N-Power Medicine
N-Power Medicine combines a community-oncology care network with clinical-trial data services for cancer drug developers.
$32MSeries B
ParticipantMG
Merck Global Health Innovation Fund
Activity from announced rounds
Activity in this selectionxyz-venture-capital-d246227f
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $107M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionInfinimmune
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
$75MSeries A
Role not disclosedDropGenie
Miniaturizes gene editing workflows to enable direct edits on primary patient cells for cell therapy and drug discovery
UndisclosedSeed+
Role not disclosed